The Map Isn’t the Milestone. What It Unlocks Is.
Seek Labs recently announced BioSeeker has mapped CRISPR-addressable regions across all 25 viral families known to infect humans. That is an important infectious disease milestone.
Archive
News
All news, publications, and updates from Seek Labs.
-
-
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery
Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping June 8, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable…
-
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing Newly issued patent covers foundational amplification chemistry designed to support sensitive molecular detection without thermal cycling or centralized laboratory infrastructure May 7, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable platforms to decode,…
-
Dr. Alison O’Mahony Named 2026 Mentor of the Year
Dr. Alison O’Mahony Named 2026 Mentor of the Year by BioHive April 28, 2026 Dr. Alison O’Mahony, Senior Vice President of Research and Development at Seek Labs, has been named Mentor of the Year as part of BioHive’s 2026 Best of BioHive Awards. The award recognizes individuals who have made exceptional contributions to mentorship and…
-
Jared Bauer Named Salt Lake City Titan 100 Honoree
Jared Bauer Named Salt Lake City Titan 100 2026 Honoree April 20, 2026 Jared Bauer, co-founder and CEO of Seek Labs, has been named a 2026 Salt Lake City Titan 100 honoree. The Titan 100 program recognizes the region’s top 100 CEOs and C-level executives, selected for their exceptional leadership, vision, and impact across industries.…
-
Seek Labs Joins BioMaP-Consortium to Support U.S. Biomanufacturing Preparedness Efforts
Seek Labs Joins BioMaP-Consortium to Support U.S. Biomanufacturing Preparedness Efforts As a member of the BioMaP-Consortium, Seek Labs gains access to a collaborative network advancing next-generation biomanufacturing and healthcare innovation. March 19, 2026 Seek Labs today announced that it has joined the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), a national public-private partnership focused on strengthening the…
-
For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics
For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics Highly pathogenic avian influenza (HPAI) illustrates a clear and urgent application for Seek Labs’ platform based programmable therapeutic. By Dr. Douglas Gladue | March 11, 2026 Highly pathogenic avian influenza (HPAI) is a persistent and economically disruptive disease threat. It has been…
-
Seek Labs Awarded $2M USDA Grant for CRISPR Avian Flu Therapeutic
Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based, Mutation-Resistant Therapeutic to Combat Avian Flu in Partnership with Canadian Food Inspection Agency USDA grant is part of a broader federal push to find innovative solutions to fight the highly infectious avian flu (HPAI), which continues to spread globally and impact egg and poultry…
-
-
Stay connected
Follow the work as it unfolds.
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.